HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells ; volume:38 ; number:1 ; day:22 ; month:7 ; year:2019 ; pages:1-15 ; date:12.2019
Journal of experimental & clinical cancer research ; 38, Heft 1 (22.7.2019), 1-15, 12.2019
- Urheber
-
Chai, Wenwen
Ye, Fanghua
Zeng, Li
Li, Yanling
Yang, Liangchun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-019-1328-3
- URN
-
urn:nbn:de:101:1-2019122221541576567536
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chai, Wenwen
- Ye, Fanghua
- Zeng, Li
- Li, Yanling
- Yang, Liangchun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Transcriptional properties of the human sodium iodide symporter and thyroglobulin genes
Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
![High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET](/assets/placeholder/searchResultMediaUnknown.png)
High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
Mesenchymal stem cell therapy using theranostic sodium iodide symporter effector gene in glioblastoma
Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy
Sodium Iodide
PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer
New insight into the transcriptional properties of the human thyrostimulin and sodium, iodide symporter genes
Wild-Type P53 Induces Sodium/Iodide Symporter Expression Allowing Radioiodide Therapy in Anaplastic Thyroid Cancer
Transcriptional properties of the human sodium iodide symporter and thyroglobulin genes
Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
Mesenchymal stem cell therapy using theranostic sodium iodide symporter effector gene in glioblastoma
Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy
Sodium Iodide
PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer
New insight into the transcriptional properties of the human thyrostimulin and sodium, iodide symporter genes
Wild-Type P53 Induces Sodium/Iodide Symporter Expression Allowing Radioiodide Therapy in Anaplastic Thyroid Cancer
Transcriptional properties of the human sodium iodide symporter and thyroglobulin genes
Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
Mesenchymal stem cell therapy using theranostic sodium iodide symporter effector gene in glioblastoma
Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy
Sodium Iodide
PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer
New insight into the transcriptional properties of the human thyrostimulin and sodium, iodide symporter genes